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Abstract
Bartonella henselae, a zoonotic agent, induces tumors of endothelial cells (ECs), namely bacillary angiomatosis and peliosis in
immunosuppressed humans but not in cats. In vitro studies on ECs represent to date the only way to explore the
interactions between Bartonella henselae and vascular endothelium. However, no comparative study of the interactions
between Bartonella henselae and human (incidental host) ECs vs feline (reservoir host) ECs has been carried out because of
the absence of any available feline endothelial cell lines.
To this purpose, we have developed nine feline EC lines which allowed comparing the effects of Bartonella strains on human
and feline micro-vascular ECs representative of the infection development sites such as skin, versus macro-vascular ECs, such
as umbilical vein.
Our model revealed intrinsic differences between human (Human Skin Microvascular ECs –HSkMEC and Human Umbilical
Vein ECs – iHUVEC) and feline ECs susceptibility to Bartonella henselae infection.
While no effect was observed on the feline ECs upon Bartonella henselae infection, the human ones displayed accelerated
angiogenesis and wound healing.
Noticeable differences were demonstrated between human micro- and macro-vasculature derived ECs both in terms of pseudo-
tube formation and healing. Interestingly, Bartonella henselae effects on human ECs were also elicited by soluble factors.
Neither Bartonella henselae-infected Human Skin Microvascular ECs clinically involved in bacillary angiomatosis, nor feline ECs
increased cAMP production, as opposed to HUVEC.
Bartonella henselae could stimulate the activation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) in homologous
cellular systems and trigger VEGF production by HSkMECs only, but not iHUVEC or any feline ECs tested.
These results may explain the decreased pathogenic potential of Bartonella henselae infection for cats as compared to humans
and strongly suggest that an autocrine secretion of VEGF by human skin endothelial cells might induce their growth and
ultimately lead to bacillary angiomatosis formation.
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Introduction
Since its discovery in 1992 [1], Bartonella henselae (B. henselae)i s
considered as the main agent of cat scratch disease (CSD) in
humans and is also responsible for a growing number of diseases in
patients [2]. This facultative intracellular bacterium is now known
to be responsible for more serious diseases in both immunocom-
petent patients,e.g. endocarditis, and immunosuppressed patients,
such as bacillary angiomatosis and peliosis [3], characterized by
pseudotumoral proliferation of endothelial cells (ECs). These
unusual vascular lesions occur mainly or exclusively in the skin,
liver and spleen [3]. Cats are the main reservoir of this zoonotic
bacterium [4]. However, as compared to humans, normal or
immunosuppressed cats display high rates of sub-clinical infections
and remain usually healthy, with only chronic bacteraemia [4,5,6].
In addition, in cats, B. henselae infection has not yet been associated
with bacillary angiomatosis or peliosis [7,8].
Two genotypes (I and II) of B. henselae have been described on the
basis of 16S rRNA sequence analysis [9]. Epidemiological studies
strongly suggest that genotype I is more virulent in humans than
genotype II [9,10,11,12,13]. In particular, only genotype I has been
found associated to date to bacillary angiomatosis and peliosis [14],
but this observation has to be confirmed by further studies.
The presence of B. henselae micro-colonies adjacent to
proliferating endothelial cells has been histologically demonstrat-
ed, and suggested that Bartonella/ECs interactions might trigger a
proangiogenic process, potentially leading to vascular lesions [15].
Due to the lack of any appropriate animal model, cultured ECs
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vascular endothelium.
These approaches have been useful for identifying B. henselae
virulence factors. B. henselae adhesin A (BadA) (originally described
as ‘‘pilus’’) [16] is important for pathogenicity [17], being involved
in the adhesion to extracellular-matrix proteins and to ECs. It
activates hypoxia-inducible factor-1 and pro-angiogenic cytokines
secretion [18]. Recently, the VirB/VirD4 type IV secretion system
and subsets of its translocated B. henselae effector proteins (BepA
and BepG) were found to modulate the angiogenic activity of B.
henselae [19,20]. Other studies have suggested that the process
through which B. henselae triggers ECs proliferation involved
released or secreted bacterial factors [21,22,23,24].
Host factors have also been found in vitro to play a role in B. henselae
driven angiogenesis. VEGF (Vascular Endothelial Growth Factor) is
known as the main angiogenic factor, which positively regulates
migration, proliferation and survival of endothelial cells and has been
shown to be over-secreted in the tumor micro-environment [25].
According to McCordet al [26], ECs infected by B.henselae Houston I
may upregulate expression and production of pro-angiogenic
proteins. Studies of VEGF expression in clinical samples [27] or in
vitro [22,27,28], suggest a paracrine loop type of VEGF activity.
Moreover, the anti-apoptotic activity of B. henselae BepA, in human
umbilical vein endothelial cells (HUVEC), correlates with an
important elevation of intracellular adenosine 39,5 9-cyclic mono-
phosphate (cAMP) level [29]. A more recent study demonstrated that
B. henselae infection involves the intrinsic apoptotic pathway [30].
ECs are morphologically and functionally heterogeneous with
major differences between those from the macro- versus micro-
circulation as documented for a variety of tissues [31,32,33].
Except rare cases where ECs of the microvasculature have been
included in Bartonella infection in vitro experiments [26,28,30,34],
studies are mostly based on the use of primary HUVEC or other
macrovasculature-derived cells like the hybrid EA.Hy.926. These
cells originate from a large vessel of the placenta and are very
different from microvasculature-derived ECs [31,32,33,35] clini-
cally involved in bacillary angiomatosis and peliosis.
In addition, primary ECs will not allow providing repeatable
and reproducible data, as these cultures lead to highly activated
cells, in limited amounts and for a short term. Cell lines,
established in a controlled identical manner, represent the best
alternative to overcome these problems.
No comparative studies on the interactions between B. henselae
and human (incidental host) ECs versus feline (reservoir host) ECs
have ever been undertaken, because of the absence of any
available feline ECs. Hence, feline ECs lines were developed and
the in vitro effects of infection by distinct Bartonella species/strains
(B. henselae genotype I/II and B. tribocorum) on human versus feline
ECs derived from the macro- and micro-vasculature were
compared. By studying various parameters as in vitro angiogenesis,
stimulation of wound-healing, induction of cAMP, production of
VEGF and activation of VEGF Receptor-2 (VEGFR-2), we
demonstrated the crucial significance of the tissue origin of ECs
and the specificity of the relationship between various strains of B.
henselae with human versus feline cell lines. Our work contributes to
the understanding of the differential outcomes of B. henselae
infection in humans versus cats.
Materials and Methods
Human endothelial cell lines
Two immortalized lines of human organospecific ECs previously
developed [31] were used in this study: one isolated from
macrovasculature (immortalized Human Umbilical Vein Endothe-
lial Cells: iHUVEC) and one isolated from the skin microvasculature
(Human Skin Microvascular Endothelial Cells: HSkMEC) [36].
Feline endothelial cell lines
Establishment. Four immature and not viable embryos were
aseptically removed at the School of Veterinary Medicine, Alfort,
France, in the reproductive diseases service by therapeutic
caesarean from queen after 45 days of gestation, and organs or
tissues biopsies were taken from each embryo. Tissues and organs
were placed in RPMI medium (Gibco, BRL, Cergy Pontoise
France) without fetal bovine serum (FBS), supplemented by
antibiotics and stored at 4uC.
Isolation of macrovascular (from umbilical vein FOmEC) or
microvascular (from Skin FSkMEC, Peripheral Lymph Node
FPLNMEC, Lung FLuMEC, Brain FBrMEC, Liver FLiMEC,
Peyer’s patches FPPMEC, Intestine FIntMEC, Heart FHeMEC)
ECs was performed [31,37,38]. Immortalization was realized as
already described for human endothelial cells [31]. Lines were
characterized, patented (CNRS-ENVA, French patent Nu 10/
00094) and deposited at the Collection Nationale de Cultures de
Microorganismes (Institut Pasteur, Paris, France).
T h ef e l i n eE C sl i n e sw e r ec u l t u r e di nO p t i M E Mm e d i u m( G i b c o
BRL,Cergy Pontoise, France) +2% of FBS+0.2% of fungizone+0.4%
of gentamicin (Gibco BRL) and were maintained in a humidified
atmosphere containing 5% carbon dioxide (CO2)a t3 7 uC.
Characterization
a- Intracellular von Willebrand factor (vWF) and
Angiotensin
-Converting Enzyme (ACE) detection. Established cell lines
were grown on twelve-well microscope slides (ICN Bio-medicals,
Aurora, OH, USA) for 48 h. Monolayers were fixed for 10 min
with paraformaldehyde (PFA, 2%) and permeabilized, for 30 min
at 37uC, with Triton X100 (0,05%) (Sigma, France).
For intracellular vWF detection, a rabbit polyclonal anti-human
vWF antibody (A0082-Dako) (20 mg/ml), was applied to the cells
for 2 h at RT and washed twice with c-PBS containing 1% bovine
serum albumin (c-PBS-BSA). The second antibody was a goat
Fluorescein IsoThioCyanate (FITC)-anti-rabbit immunoglobulin
antibody (20 mg/ml) (SBE, CliniSciences, Montrouge, France),
and cells were further incubated for overnight at 4uC.
For ACE detection, polyclonal rabbit anti-human ACE
antibody (sc 20791- Santa Cruz Biotechnology) and, further, a
secondary goat Fluorescein IsoThioCyanate (FITC)-anti-rabbit
immunoglobulin antibody (SBE, CliniSciences, Montrouge,
France) was used. Cells were examined by fluorescence micros-
copy (Leica DMI 4000 B).
b- Angiogenesis assays. A 96-well plate (Falcon, BD
Biosciences, Grenoble, France) was coated with Matrigel
TM (BD
Biosciences) mimicking the extracellular matrix (40 ml by well).
The Matrigel
TM was allowed to polymerize for 1 h at 37uC before
cell seeding (8610
3 cells/well). ECs rearrangements and capillary-
like structure formation were observed each hour until the 24
th
hour and then every day until the 7
th day. It was photographed
regularly under a microscope (Nikon TMS, Japan)
Monkey kidney epithelial cells (Vero line, ATCC, CCL-81)
were used as a non endothelial cell control.
Bacterial strains
Four strains of B. henselae were used, based on their species
origin (human or feline) and genotype (I or II). The two strains
isolated from human patients were the reference strain Houston-1
(genotype I (H1) / ATCC 49882) [1] and the genotype II
Marseille strain (H2) kindly supplied by Jean Marc Rolain (Unite ´
Bartonella Endothelial Cells Interactions
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cats were a genotype I strain (F1/ Strain 297172) kindly supplied
by Bruno Chomel (University of California, Davis, USA) and a
genotype II B. henselae strain initially isolated in our laboratory (F2).
B. tribocorum (Bt) (CIP 105476 T), isolated from rat and without
known pathogenicity for human and cats was also used.
All Bartonella strains were cultured on sheep blood agar medium
(BioMerieux, Craponne, France) for 5 to 7 days in humidified
atmosphere at 35uC and 5% CO2.
To investigate the specificity of Bartonella-triggered angiogenesis,
we used Escherichia coli (DH5a) (Invitrogen, France) as a negative
control. This bacterium was grown at 37uC on Luria-Bertani (LB)
agar or in LB broth (Sigma, France). Heat-inactivated B. henselae
were used in order to check if dead bacteria were still able to
stimulate ECs angiogenesis. The inactivation of heat-treated
bacteria (56uC, 30 min) was checked on sheep blood agar
medium.
Generation of Bartonella culture supernatants
B. henselae strains and B. tribocorum were harvested from blood
agar plates and suspended in Schneider medium 1x (Gibco,
France). The bacterial cultures were gently shaken in Schneider
medium for 18 h at 200 rpm and 37uC on an orbital shaker
(Innova 4230, New Brunswick Scientific, Edison, NJ, USA). After
18 h of incubation, the suspensions were removed from the flasks
and spun at 1000 g and 4uC for 10 minutes to form a soft pellet.
The supernatants were removed and passed through a 0.22 mm
filter to remove all bacteria. The bacteria-free supernatants were
dialyzed with OptiMEM and concentrated in a Centrifugal filter
(Amicon H Ultra-15 Millipore, France). Culture supernatant
control medium was also generated through similar methods.
Protein concentrations were determined by bicinchoninic acid
assay (BC Assay Kit, Uptima, Interchim, France).
In vitro induction of angiogenesis
Twenty-four hours before infection of ECs (iHUVEC -
immortalized Human Umbilical Vein Endothelial Cells-,
HSkMEC -Human Skin Microvascular Endothelial Cells-,
FOmEC-Feline Umbilical vein Macrovascular Endothelial Cells
and FSkMEC-Feline Skin Microvascular Endothelial Cells),
antibiotics were removed from the culture medium. ECs (8610
3
cells/well) were infected with Bartonella at a multiplicity of infection
(M.O.I.) of 50, 100 and 150 bacteria per cell or treated with
bacteria culture supernatant (protein concentration: 250 mg/ml)
and then were seeded on 96 well plates previously coated with
Matrigel
TM (BD Biosciences, Grenoble, France). Videos for ECs
rearrangement and capillary-like structure formation were ac-
quired and registered for image analysis (Zeiss axiovision
program). The Zeiss axiovert 200 M, videomicroscope equipped
for temperature, gas and humidity controls was used to acquire
images in time lapse conditions and reconstitute the kinetics of the
angiogenesis dynamic process. The pseudo-vessel formation was
monitored continuously during the first 24 hours and then
observed every day during the following 7 days.
Capillary-like structure formation was quantified by measuring
the length of tubes and counting the branching points [39].
Healing test
iHUVEC, HSkMEC, FOmEC and FSkMEC were seeded in
24-well plates at a density of 10
5 cells/well and allowed to attach
overnight in OptiMEM medium without antibiotics. When cells
came to confluence, a wound was made in the center of the well
using the extremity of a sterile pipette tip. Then, ECs were infected
with bacteria (100 M.O.I.) for 24 h. The healing was observed and
photographed under a Nikon TMS microscope. Healing distances
(in mm) were measured at time 0 and 24 h after the wound.
Determination of intracellular cAMP level
After infection of ECs (iHUVEC, HSkMEC, FOmEC and
FSkMEC) by Bartonella strains with 150 M.O.I.for 30 h in 24 well
plates, cells were washed with PBS and lysed. Intracellular cAMP
levels were determined by the EIA system (Biotrak, Amersham,
Biosciences, France) as described by the manufacturer.
Measurement of VEGF levels in conditioned medium
(ELISA)
VEGF concentration in culture medium was measured using a
commercially available human VEGF ELISA Kit (R&D Systems,
Minneapolis, MN, USA) according to the manufacturer’s
instructions. Briefly, cells were plated at a density of 5610
4
cells/0,5 ml/well in a 24 well plate and 12 h later cells were
infected with Bartonella at a M.O.I. of 100. Conditioned medium
was collected 72 h after infection, cellular debris and extracellular
bacteria removed by centrifugation, and the medium was kept at
280uC until VEGF quantitation was undertaken. Cell number
was determined immediately after medium recovery.
Western blot analysis of VEGF-R2
24 h after infection (M.O.I.of 100), iHUVEC, HSkMEC,
FOmEC and FSkMEC were lysed in TNT lysis buffer (10 mM
Tris-HCL pH 7.5; 150 mM NaCL; 1% Nonidet P-40; 1% Triton
X100 and 2 mM EDTA) supplemented with protease and
phosphatase inhibitors (10 mg/ml leupeptin and apropotin;
1 mM phenylmethylsulfonyl fluoride; 25 mM NaF and 300 mM
vanadate) for 15 min at 4uC. Equal amounts of samples were
subjected to SDS-polyacrylamide gel electrophoresis and trans-
ferred onto a polyvinylidene difluoride membrane. Membranes
were incubated with either anti-VEGFR-2 or anti-phosphorylated
Y1175 VEGFR-2 (Cell signaling, Ozyme, Saint-Quentin-en-
Yvelines, France). Daylight680 fluorescent dye-conjugated sec-
ondary antibody was used for revelation and membranes were
scanned using the Odyssey Infra-Red Imaging System (Li-Cor
BioSciences, EuroSep, Cergy-Pontoise, France).
Statistical analysis
All experiments were performed at least three times (except
VEGF production: twice) and gave comparable results. Differenc-
es between mean values of experimental and control groups were
analyzed by Student’s t-test. P-values less than 0.05 were
considered to be statistically significant. The data were expressed
as mean 6 standard deviation (SD).
Results
Establishment of new feline endothelial cell lines
In order to compare the feline ECs with their human
counterparts (i.e HSkMEC – Human Skin Microvascular EC -
and iHUVEC – immortalized Human Umbilical Vein EC -),
two feline cell lines (FSkMEC - Feline Skin Microvascular EC -
and FOmEC- Feline Umbilical Macrovascular EC -) were
selected among the nine established feline ECs lines which have
been characterized for EC markers as vWf and ACE (data not
shown).
Moreover, because ECs can retain in vitro their ability to
undergo angiogenesis, feline ECs lines were tested for their
potentiality to form capillary-like structures in the classical
Matrigel
TM assay. All feline ECs were capable of performing
Bartonella Endothelial Cells Interactions
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TM. Figure 1 shows angiogenesis observed
with FSkMEC and FOmEC.
Angiogenic response of ECs to Bartonella infection
Capillary-like structures of uninfected feline ECs (Fig. 1) began
to form within two hours after seeding on Matrigel
TM as compared
to uninfected human ECs, while occurring within approximately
five hours for macrovasculature derived ECs (iHUVEC) and
within 10 hours for microvasculature ECs (HSkMEC) (table 1).
The network of pseudo-vessels persisted in human ECs, until
24 hours for macro-vasculature derived ECs and until 7 days for
microvascular ECs. Of note this network disappeared only after
20 hours with feline ECs (table 1).
In parallel, we monitored the effects of Bartonella (B. henselae
genotype I/II and B. tribocorum) infection on the four cell lines.
Irrespective of the species of origin and genotypes of Bartonella,
infected HSkMEC efficiently achieved angiogenesis in terms of
tube formation, extended projections morphology, branching
points and number of cells as compared to uninfected cells
(Fig. 2 A). The influence of Bartonella infection on the formation of
the capillary-like network by HSkMEC was dose-dependent (data
not shown). Infection accelerated angiogenesis by few hours in
Human Skin Microvascular cells (table 1).
Importantly, kinetics of angiogenesis of the FSkMEC was not
changed upon Bartonella infection whatever strain used (Fig. 2B,
Fig. 3B and table 1). Angiogenesis of FSkMEC and FOmEC
started 2 h after seeding on Matrigel
TM. The destruction of the
network was slightly faster in the infected feline cell lines
(18 hours) as compared to uninfected cells (20 hours) (table 1).
No effect was observed upon infection on the structure of the
newly formed vessels (Fig. 2B and Fig. 3B). Importantly, as a
negative control, no pro-angiogenic effect was observed, both on
human and feline ECs with E. coli or with heat-inactivated B.
henselae (data not shown).
The observed effects were quantified. As shown on Fig. 3A,
Bartonella-infection increased capillary-like formation by HSkMEC
by a factor 1.8 to 2.6 as compared to uninfected ECs (p,0.05) and
the number of branching points by a factor of 1.78 to 3 (p,0.05)
(Fig. 3 A). This network was observed until 7 days with these cells,
and then disappeared (table 1).
Capillary-like formation was increased in iHUVEC by a 2 fold
upon infection such as in HSkMEC. However, as opposed to
HSkMEC, B. henselae infectiondidnot speedthiseffect (table 1).The
networkwasobservedonlyuntil24 hours,beforeresorbing(table1).
Thus, the effect of Bartonella-induced angiogenesis was more
potent in human ECs than feline ECs (where infection even
accelerated network destruction). Moreover, capillary-like struc-
tures were markedly more durable in micro- versus macro-
vasculature ECs.
Figure 1. In vitro angiogenesis of feline ECs 10 h after seeding on Matrigel
TM. Feline ECs are able to form pseudovessels. FOmEC: Feline
Umbilical Vein Endothelial Cells; FSkMEC: Feline Skin Microvascular Endothelial Cells. Vero cells: Monkey kidney epithelial cells used as non-
endothelial control cells. Original magnification: 50x.
doi:10.1371/journal.pone.0020204.g001
Table 1. Effect of Bartonella on ECs angiogenesis kinetics.
Feline EC Human EC
unifected infected uninfected infected
Beginning of angiogenesis Macrovascular 2 h 2 h 5 h 5 h
Microvascular 2 h 2 h 10 h 8 h
End of angiogenesis Macrovascular 20 h 18 h 24 h 24 h
Microvascular 20 h 18 h 7days 7 days
Acceleration of the pseudovessel rearrangement induced by infection with B. henselae strains or their supernatants was observed only with human microvasculature-
derived ECs (HSkMEC). In feline cells, bacterial infection accelerates the network destruction. Noticeably, uninfected human ECs from micro- and macro-vasculature
display differences in the angiogenesis kinetics.
Similar results were obtained when ECs were treated by corresponding B. henselae supernatants.
Results from one out of four independent experiments are shown.
Human Macrovascular EC: immortalized Human Umbilical Vein Endothelial Cells (iHUVEC); Human Microvascular EC: Human Skin Microvascular Endothelial Cells
(HSkMEC); Feline Macrovascular EC: Feline Umbilical Vein Endothelial Cells (FOmEC); Feline Microvascular EC: Feline Skin Microvascular Endothelial Cells (FSkMEC).
doi:10.1371/journal.pone.0020204.t001
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TM. HSkMEC
(Human Skin Microvascular Endothelial Cells) infection by B. henselae (multiplicity of infection: 100 bacteria/cell) increases capillary-like structure
formation as compared to uninfected cells (A). In contrast, B. henselae infection has no visible effect on FSkMEC (Feline Skin Microvascular Endothelial
Cells) (B). Pictures have been taken 10 h and 20 h after seeding of FSkMEC and HSkMEC, respectively. Original magnification: 50x. H1: B. henselae
human type I strain (reference strain Houston-1 ATCC 49882); H2: B.henselae human type II strain (Marseille); F1: B. henselae feline type I strain (F1
297172); F2: B. henselae feline type II strain; Bt: B. tribocorum.
doi:10.1371/journal.pone.0020204.g002
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supernatants
In order to investigate the effects of Bartonella secretome,
different Bartonella culture supernatants were generated and tested
for their ability to induce angiogenesis in human and feline ECs.
Bartonella culture supernatants did induce tube formation in human
ECs. The pro-angiogenic responses obtained with Bartonella culture
supernatants were accelerated by a factor 1.9 to 2.5 (p,0.05), as in
Bartonella-infected human ECs (Fig. 3A). The resulting effect of
Bartonella or their culture supernatants on the morphology of
human ECs was similar, i.e. ECs appeared elongated with long
membrane projections (data not shown).
In the system of feline endothelial cells, Bartonella culture
supernatants, as bacteria themselves, did not influence angiogen-
esis (Fig. 2B and Fig. 3B).
Wound-induced migration of human ECs by Bartonella
infection
As ECs migration is an essential step for angiogenesis, the
significance of the site of infection in term of endothelium
susceptibility was examined. The endothelial cell reaction
according to their tissue origin was followed upon Bartonella
infection by measuring their migration speed to heal a mechanical
wound (Fig. 4A and 4B). In uninfected cells (at 24 h), wound-
healing was at least twice faster in iHUVEC than in HSkMEC
(4.560.7 and 1.2560.35 mm within 24 h, respectively with
p=0.015) (Fig. 4C). Infection speeded the wound-healing for both
iHUVEC and HSkMEC. Remarkably, in iHUVEC, healing
speed was approximately doubled, whereas in HSkMEC, it was
increased by a factor of 4.3 up to 7.8 (p,0.05) (Fig. 4).
In feline ECs (FOmEC and FSkMEC) wound-induced
migration was recorded and no stimulation by Bartonella infection
was observed (Fig. 4A and Fig. 4C).
Effect of Bartonella infection on human and feline ECs on
cAMP production
It was shown in the HUVEC model that B. henselae genotype I
(reference strain Houston-1) triggered the production of cAMP
[29]. As, according to these authors, anti apoptosis was mediated
through increased cAMP levels, this induction was assessed in ECs
upon infection by distinct Bartonella strains. In uninfected ECs of
the macro- or the micro-vasculature, the levels of cAMP produced
by the feline ECs (FOmEC [12.0667.13 fmol] and FSkMEC
[19.3864.11 fmol]) were significantly weaker than in human ECs
(iHUVEC [203.57657.66 fmol] and HSkMEC [32.686
1.80 fmol]) (p,0.05) (Fig. 5). Moreover, cAMP production by
human ECs of the macrovasculature (iHUVEC) was higher than
microvasculature-derived ECs (HSkMEC) by a factor of 6.2
(203.57657.66 vs 32.6861.80 fmol respectively with p=0.0004).
In feline ECs, the low levels of production did not allow to detect
any significant difference between ECs of the macro- and the
micro-vasculatures (Fig. 5).
Upon infection, cAMP increased only in human macrovascu-
lature ECs (iHUVEC) infected by strain H1 by a factor of 2.2
(reaching 405.1666.72 fmol) (p,0.05). Strains F1, F2 and Bt did
not induce any change. Human Skin Microvasculature ECs were
not affected by any of the strains.
Feline ECs from micro- or macro-vasculature ECs did not react
to the bacterial infection (Fig. 5).
Bartonella increases VEGF production in human
microvascular ECs
The involvement of VEGF in B. henselae effect on angiogenesis
was investigated. We took into account: a) the origin of the
bacterial strains (human versus feline); b) the bacterial genotype (I
versus II); c) the ECs species (human versus feline), and d) their type
(macro versus micro vessels derived-ECs).
Figure 3. Quantitative analysis of capillary-like structure formation by cell projection length and branching point number
determination. Human Skin Microvascular ECs (HSkMEC) infection by B. henselae strains (M.O.I.of 100, black bars) or treatment by their culture
supernatants (250 mg/ml, grey bars) increases angiogenesis assessed by cell projection length and branching point number when compared to
uninfected cells (white bars) (measures performed 20 hours p.i.) (A). In contrast, Feline Skin Microvascular ECs (FSkMEC) infection by B. henselae or
treatment by their culture supernatants has no such effect (measures performed 10 hours p.i.) (B). Data from four independent experiments are
shown as mean 6 standard deviation (*p,0.05 versus uninfected or untreated controls). NSI: No Significant Increase. C: uninfected or untreated
controls cell; S: Bartonella culture supernatant; H1: B. henselae human type I strain (reference strain Houston-1 ATCC 49882); H2: B. henselae human
type II strain (Marseille); F1: B. henselae feline type I strain (F1 297172); F2: B. henselae feline type II strain; Bt: B. tribocorum.
doi:10.1371/journal.pone.0020204.g003
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infected microvascular and macrovascular ECs both of human
and feline origin as shown on Fig. 6. Human and feline
microvascular ECs produced high levels of VEGF
[717.88632.50 and 1623.19672.81 pg/ml respectively] as com-
pared to human and feline macrovascular ECs [3.7563.12 and
6.8865.0 pg/ml respectively, p=0.001] (Fig. 6).
An increase in VEGF production by B. henselae infection was
induced only in human microvascular skin-derived cells
(HSkMEC) (Fig. 6).
Interestingly, the four B. henselae strains significantly increased
VEGF production by HSkMEC by a factor of 2.1 to 2.4 while B.
tribocorum was less effective (factor of 1.3) (p,0.05). Feline
microvascular cells production of VEGF was not significantly
affected by the various strains.
Effects of B. henselae infection on VEGFR-2 activation
The level of activation of the VEGF receptor VEGFR-2 was
estimated by monitoring VEGFR-2 phosphorylation in Western-
blot. Figure 7 indicates that ECs (iHUVEC, HSkMEC, FOmEC
and FSkMEC) infection by Bartonella was associated with an
increased phosphorylation of VEGFR-2.
In addition, the level of the VEGFR-2 phosphorylated form
was significantly higher by a 2 fold when ECs were infected by a
strain originating from a homologous host (i.e. when human ECs
were infected by B. henselae strains originating from humans and
when feline ECs were infected by B. henselae strains originating
from cats). In particular, VEGFR-2 phosphorylation induced in
human ECs (HSkMEC and iHUVEC) by strain H1 was
respectively 2.2 to 3.3 higher than that induced by F1.
Conversely, VEGFR-2 phosphorylation induced in Feline ECs
(FSkMEC and FOmEC) by H1 was lower than that induced by
F1 respectively 0.95 to 0.6 (Fig. 7A and 7B). B. tribocorum induced
a comparable activation of VEGFR-2, whatever the origin of cell
lines (Fig. 7A).
Discussion
B. henselae is a facultative intracellular pathogen associated with
the induction of vasoproliferative tumors in humans (bacillary
angiomatosis and peliosis) that are not observed in cats (host
reservoir) [4,6,7,8].
Our original cellular models allowed us to reveal intrinsic
differences in the angiogenesis kinetics and the wound-healing
process between human micro- and macro-vasculature-derived
ECs. Importantly, our results strongly suggest that effects of B.
henselae on microvasculature-derived cells strongly differ from
macrovasculature ones.
In human cells, Bartonella infection affected the angiogenic
process at two different levels: a) a slight acceleration of the
pseudovessel rearrangement was observed, only with microvascu-
lature-derived ECs (Table 1) and b) the number of pseudo-vessels
was increased in both micro- and macro-vasculature-derived ECs
(figure 3).
One key point of our findings concerns feline ECs from both
micro- and macro-vasculatures. Indeed, not only B. henselae had no
visible pro-angiogenic effect in vitro, but the infection seemed to
accelerate the network destruction of the feline cells. These results
might recapitulate the clinical situation, i.e. the absence of bacillary
angiomatosis in cats (even in FIV and/or FeLV infected cats) versus
bacillary angiomatosis in humans and even in dogs as recently
described [40].
Hence, our cellular models are relevant to understand the
cellular and molecular bases of the pro-angiogenic potential of B.
Figure 4. Effect of human and feline ECs Bartonella infection on
cell migration assessed in wound healing assay. A: Healing test
(FSkMEC and FSkMEC-H1) Healing distance = D 2 d. B: Healing test
(HSkMEC and HSkMEC-H1) C: Quantification of the effect of Bartonella
infection on wound healing B. henselae infection increased strongly
human Skin Microvascular ECs (HSkMEC) migration, in a less extent
human macrovascular ECs (iHUVEC) migration but did not affect feline
ECs (FOmEC and FSkMEC). Results show mean 6 standard deviation
from three independent experiments. (iHUVEC versus HSkMEC controls:
"p=.015; infected cells versus uninfected cells: *p,0.05). NSI: No
Significant Increase. H1: B. henselae human type I strain (reference strain
Houston-1 ATCC 49882); H2: B. henselae human type II strain (Marseille);
F1: B. henselae feline type I strain (F1 297172); F2: B. henselae feline type
II strain; Bt: B. tribocorum.
doi:10.1371/journal.pone.0020204.g004
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angiomatosis/peliosis.
This model of infection shows that, independently of the
bacterial species (B. henselae vs B. tribocorum), or of the B. henselae
genotype (I or II), Bartonella tested here can induce in vitro
angiogenesis. Interestingly, B. tribocorum has no known pro-
angiogenic potential in vivo. Moreover we did not detect any
obvious difference of activity between the different strains of
Bartonella tested contrary to the work of Chang et al[30].
Furthermore, the stimulatory effect of B. henselae is not
dependent upon attachment or penetration in the target cell
suggesting that B. henselae may produce and secrete endothelial
cell-stimulatory factor(s).
In addition, the inactivation of B. henselae by heat treatment
abolished its vasoproliferative activity, suggesting that the
angiogenic effect of B. henselae on ECs require live bacteria.
Previous studies dedicated to understand the interactions
between primary HUVEC and B. henselae Houston 1 (genotype
1) have suggested a correlation between the anti-apoptotic activity
of B. henselae and an increased cAMP production [29]. Remark-
ably, in our study, the stimulation of cAMP production was
observed only when B. henselae Houston 1 was inoculated to
Figure 5. Effect of B. henselae infection on intracellular cAMP production in human and feline EC lines. B. henselae infection did not
significantly increase cAMP production by ECs, except for iHUVEC infected by H1 strain. Results were monitored 30 h post infection with bacteria
(M.O.I. of 150) and expressed in fmol/well as mean 6 standard deviation (*p,0.05 for the differences between infected cells versus uninfected cells;
#, " and & p,0.05, for the differences between uninfected cells). H1: B. henselae human type I strain (reference strain Houston-1 ATCC 49882); F1: B.
henselae feline type I strain (F1 297172); F2: B. henselae feline type II strain; Bt: B. tribocorum. iHUVEC: immortalized Human Umbilical Vein Endothelial
Cells; HSkMEC: Human Skin Microvascular Endothelial Cells; FOmEC: Feline Umbilical Vein Endothelial Cells; FSkMEC: Feline Skin Microvascular
Endothelial Cells.
doi:10.1371/journal.pone.0020204.g005
Figure 6. VEGF production in human and feline macro- and micro-vascular ECs upon infection with Bartonella strains. B. henselae
triggers VEGF production in Human Skin Microvascular ECs (HSkMEC) but not in human macrovascular ECs (iHUVEC) or in feline macro- (FOmEC:
Feline Umbilical vein Endothelial Cells) or micro- (FSkMEC: Feline Skin Microvascular Endothelial Cells) vascular ECs. In addition, a clear differential
production of VEGF between micro- and macro-vascular ECs is shown both in human and in cat. VEGF level was determined by ELISA after 72 h of
infection and data shown as mean 6 standard deviation (*p,0.05 infected versus uninfected cells; " and #p,0.0015 for the differences between
uninfected cells). NSI: No Significant Increase. iHUVEC: immortalized Human Umbilical Vein Endothelial Cells; HSkMEC: Human Skin Microvascular
Endothelial Cells; FOmEC: Feline Umbilical Vein Endothelial Cells; FSkMEC: Feline Skin Microvascular Endothelial Cells. H1: B. henselae human type I
strain (reference strain Houston-1 ATCC 49882); H2: B. henselae human type II strain (Marseille); F1: B. henselae feline type I strain (F1 297172); F2: B.
henselae feline type II strain; Bt: B. tribocorum.
doi:10.1371/journal.pone.0020204.g006
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HSkMEC –, which are directly involved in bacillary angiomatosis,
were used, even when they were infected by Houston 1. This
points to the fact that macrovasculature-derived ECs (iHUVEC/
HUVEC) deeply differ from microvasculature ECs
[31,32,33,41,42]. Remarkably, in our study, cAMP production
does not reflect ECs proliferation in the case of infected
microvascular ECs. According to these results, microvascular skin
endothelial cells- HSkMEC, clearly represent a better model for
clinical bacillary angiomatosis.
Feline macro- and/or micro-vasculature ECs cAMP production
was weak and not related to infection.
Such low level of cAMP production by human microvascula-
ture ECs (HSkMEC) does not corroborate the pro-angiogenic
effect of B. henselae interaction with human ECs. Nishihara et al
[43], have shown that the effects of cAMP are highly cell type-
specific. cAMP either promotes or antagonizes apoptosis in a cell
type, environment- and stimulus- related manner. These,
together with our results, illustrate that the model based on
HUVEC which is not the clinical cell target, does not allow any
definitive conclusion about the role of cAMP during B. henselae-
anti-apoptotic activity.
VEGF, one of the main pro-angiogenic factors, plays a critical
role in blood vessel formation [44] and pathological angiogenesis
[45]. This factor seems also to be involved in Bartonella-induced
angiogenesis. For instance, in verruga peruana (induced by B.
baciliformis), the primary source of vascular endothelial growth
factor (VEGF) is the epidermis [46] and endothelium of verruga
peruana expresses VEGF receptors (VEGFR1 and VEGFR2)
[46].
In addition, while HUVEC did not produce VEGF in response
to B. henselae, infection promotes their proliferation [22]. Further
study by Kempf et al showed the importance of VEGF in B.
henselae-mediated ECs proliferation although it appeared not to be
produced by ECs only. Overall, this strongly suggests that a
paracrine loop could be involved in B. henselae VEGF action
[27,28]. However, up to now, the majority of these studies have
been carried out on macrovascular ECs (i.e. HUVEC). Interest-
ingly, using our species- and organ-specific ECs model, we showed
that B. henselae increased VEGF production by Human Skin
Microvascular ECs but not by iHUVEC or feline macro- or
micro-vascular ECs. These results, which might explain the
decreased pathogenic potential of B. henselae infection for cat as
compared to human, strongly suggests the involvement of an
autocrine secretion of VEGF by skin ECs. This finding points out
that the mechanism of B. henselae-mediated angiogenesis induction
implies autocrine VEGF production and stimulation of the
infected endothelium.
In parallel to VEGF production, the phosphorylation of
VEGFR-2 was observed in ECs upon infection, mostly by
homologous strains. This phenomenon is of high interest in the
context of epidemiological human infection. As B. henselae isolates
infecting a human have always a feline origin, it is tempting to
speculate that an adaptive switch is taking place upon cat scratch
in humans. Altogether, our results raise the hypothesis of host-
dependent signaling in ECs upon bacterial infection as VEGFR-2
activation is more prominent in human ECs exposed to
homologous strains. The same holds true for feline ECs. Because
bacillary angiomatosis is not detected in cats infected by
homologous strains, alternate mechanisms are likely taking place,
Our results support the fact that VEGF signaling might be
increased in human ECs through an autocrine production, which
does not occur in feline ECs. Paracrine VEGF activation cannot
be excluded; therefore, it will be interesting to further investigate
whether VEGF can be released in the perivascular microenviron-
ment by other cells, such as macrophages and polymorphonuclear
cells. Our results on VEGF and VEGFR-2 are in apparent
contradiction with those obtained by Scheidegger et al [47].
However, the concentration ranges and source of VEGF were far
for being comparable.
Our study highlights the ECs organo- and species- specificity in
their interactions with B. henselae. Indeed, our model further
Figure 7. B. henselae -mediated VEGFR-2 activation on ECs. A:
Homologous type of B. henselae -mediated VEGFR-2 activation on ECs.
B. henselae strains from human origin (H1 and H2) mostly stimulated
VEGFR-2 phosphorylation in human ECs (HUVEC an HSkMEC) and the
strains from feline origin (F1 and F2) stimulated VEGFR-2 phosphory-
lation in feline ECs (FOmEC and FSkMEC). Western blot analysis of
VEGFR-2 and phosphorylated VEGFR-2 (pVEGFR-2) following a 24 hours
infection of ECs by B. henselae were shown as one representative
experiment out of three. iHUVEC: immortalized Human Umbilical Vein
Endothelial Cells; HSkMEC: Human Skin Microvascular Endothelial Cells;
FOmEC: Feline Umbilical Vein Endothelial Cells; FSkMEC: Feline Skin
Microvascular Endothelial Cells. H1: B. henselae human type I strain
(reference strain Houston-1 ATCC 1 49882); H2: B. henselae human type
II strain (Marseille); F1: B. henselae feline type I strain (F1 297172); F2: B.
henselae feline type II strain; Bt: B. tribocorum; - : Uninfected cells. B:
Quantitative analysis of Bartonella-mediated VEGFR-2 activation on ECs.
Bartonella strains effect on VEGFR-2 activation expressed as levels
increase over uninfected controls. ECs (iHUVEC, HSkMEC, FOmEC and
FSkMEC) infection by Bartonella was associated with an increased
phosphorylation of VEGFR-2. Serie 1 (White bar): iHUVEC: immortalized
Human Umbilical Vein Endothelial Cells. Serie 2 (Light grey bar):
HSkMEC: Human Skin Microvascular Endothelial Cells. Serie 3 (Dark grey
bar): FOmEC: Feline Umbilical Vein Endothelial Cells. Serie 4 (Black bar):
FSkMEC: Feline Skin Microvascular Endothelial Cells. H1: B. henselae
human type I strain (reference strain Houston-1 ATCC 49882); H2: B.
henselae human type II strain (Marseille); F1: B. henselae feline type I
strain (F1 297172); F2: B. henselae feline type II strain.
doi:10.1371/journal.pone.0020204.g007
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feline ECs on the one hand and by the macro- vs the micro-
vasculature on the other hand. Additionally, local physiological
microenvironment is most likely to play an important role. In this
context, our cellular systems will allow studying the process of
specific ECs infection by B. henselae. They will offer new
possibilities to investigate bacterial and cellular factors which
determine human vs cat reactivity, as well as the mechanisms
involved in anti-apoptotic and/or pro-angiogenic effects, ultimate-
ly resulting to bacillary angiomatosis and peliosis only in humans.
In conclusion, according to the validated hypothesis stating the
organospecificity of the endothelium [31,36,37,38], our work
extends this concept to the species-specific endothelial cell
phenotypes. In this scenario, ECs could act as a major reservoir
for infectious pathogens. Moreover, at a second level the ECs from
the same tissue but from different species display similar
organospecificity but distinct responses to infection. This is clearly
illustrated by the reactivity of the human skin-derived ECs
compared to the feline skin-derived ECs. It will further be
necessary to evidence the molecular mechanism by which feline
ECs are recognized but not activated upon binding of B henselae,
while human ECs are activated to grow and proceed to tumor-like
state. The co-activation signaling should indicate differential gene
induction and regulation processes.
Such information will provide new insights into the mechanisms
of species-specific tolerance versus pathologic infections as observed
in AIDS malignancies.
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